159 related articles for article (PubMed ID: 29885423)
1. Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries.
Guennoun R; Fréchou M; Gaignard P; Liere P; Slama A; Schumacher M; Denier C; Mattern C
Neuropharmacology; 2019 Feb; 145(Pt B):283-291. PubMed ID: 29885423
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
Fréchou M; Zhu X; Kumar N; Sitruk-Ware R; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2021 Oct; 198():108760. PubMed ID: 34437904
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent and long-term cerebroprotective effects of intranasal delivery of progesterone after ischemic stroke in male mice.
Fréchou M; Zhu X; Liere P; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2020 Jun; 170():108038. PubMed ID: 32151648
[TBL] [Abstract][Full Text] [Related]
5. Progesterone for the treatment of experimental brain injury; a systematic review.
Gibson CL; Gray LJ; Bath PM; Murphy SP
Brain; 2008 Feb; 131(Pt 2):318-28. PubMed ID: 17715141
[TBL] [Abstract][Full Text] [Related]
6. Progesterone for neuroprotection in pediatric traumatic brain injury.
Robertson CL; Fidan E; Stanley RM; Noje C; Bayir H
Pediatr Crit Care Med; 2015 Mar; 16(3):236-44. PubMed ID: 25581631
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.
Sun BL; He MQ; Han XY; Sun JY; Yang MF; Yuan H; Fan CD; Zhang S; Mao LL; Li DW; Zhang ZY; Zheng CB; Yang XY; Li YV; Stetler RA; Chen J; Zhang F
Mol Neurobiol; 2016 Jan; 53(1):320-330. PubMed ID: 25432887
[TBL] [Abstract][Full Text] [Related]
8. Progesterone in the clinical treatment of acute traumatic brain injury.
Stein DG; Wright DW
Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of progesterone treatment for ischaemic stroke.
Gibson CL; Bath PM
J Cereb Blood Flow Metab; 2016 Mar; 36(3):487-91. PubMed ID: 26661235
[TBL] [Abstract][Full Text] [Related]
10. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update.
Stein DG
Neuroscience; 2011 Sep; 191():101-6. PubMed ID: 21497181
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.
Pandya JD; Musyaju S; Modi HR; Okada-Rising SL; Bailey ZS; Scultetus AH; Shear DA
J Transl Med; 2024 Feb; 22(1):167. PubMed ID: 38365798
[TBL] [Abstract][Full Text] [Related]
12. Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration.
Ducharme N; Banks WA; Morley JE; Robinson SM; Niehoff ML; Mattern C; Farr SA
Eur J Pharmacol; 2010 Sep; 641(2-3):128-34. PubMed ID: 20570588
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.
Howard RB; Sayeed I; Stein DG
J Neurotrauma; 2017 Jun; 34(11):1915-1918. PubMed ID: 26370183
[TBL] [Abstract][Full Text] [Related]
14. Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy.
Wong R; Ray D; Kendall DA
J Pharm Pharmacol; 2012 Nov; 64(11):1614-20. PubMed ID: 23058048
[TBL] [Abstract][Full Text] [Related]
15. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
Sayeed I; Stein DG
Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
[TBL] [Abstract][Full Text] [Related]
16. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats.
O'Connor CA; Cernak I; Johnson F; Vink R
Exp Neurol; 2007 May; 205(1):145-53. PubMed ID: 17362936
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of progesterone for moderate to severe traumatic brain injury: a meta-analysis of randomized clinical trials.
Lin C; He H; Li Z; Liu Y; Chao H; Ji J; Liu N
Sci Rep; 2015 Aug; 5():13442. PubMed ID: 26304556
[TBL] [Abstract][Full Text] [Related]
19. Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection.
Guennoun R; Labombarda F; Gonzalez Deniselle MC; Liere P; De Nicola AF; Schumacher M
J Steroid Biochem Mol Biol; 2015 Feb; 146():48-61. PubMed ID: 25196185
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
